bupropion has been researched along with Diabetic Neuropathies in 2 studies
Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.
Diabetic Neuropathies: Peripheral, autonomic, and cranial nerve disorders that are associated with DIABETES MELLITUS. These conditions usually result from diabetic microvascular injury involving small blood vessels that supply nerves (VASA NERVORUM). Relatively common conditions which may be associated with diabetic neuropathy include third nerve palsy (see OCULOMOTOR NERVE DISEASES); MONONEUROPATHY; mononeuropathy multiplex; diabetic amyotrophy; a painful POLYNEUROPATHY; autonomic neuropathy; and thoracoabdominal neuropathy. (From Adams et al., Principles of Neurology, 6th ed, p1325)
| Excerpt | Relevance | Reference |
|---|---|---|
| " The purpose of this single-blind, prospective study was to determine sexual side effects, both positive and negative, of the amino-ketone antidepressant bupropion in a group of nondepressed diabetic men with somatic erectile dysfunction." | 9.08 | Bupropion and sexual function: a placebo-controlled prospective study on diabetic men with erectile dysfunction. ( Culver, A; Davidson, JM; Myers, L; Rowland, DL, 1997) |
| " The purpose of this single-blind, prospective study was to determine sexual side effects, both positive and negative, of the amino-ketone antidepressant bupropion in a group of nondepressed diabetic men with somatic erectile dysfunction." | 5.08 | Bupropion and sexual function: a placebo-controlled prospective study on diabetic men with erectile dysfunction. ( Culver, A; Davidson, JM; Myers, L; Rowland, DL, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Majd, H | 1 |
| Amin, S | 1 |
| Ghazizadeh, Z | 1 |
| Cesiulis, A | 1 |
| Arroyo, E | 1 |
| Lankford, K | 1 |
| Majd, A | 1 |
| Farahvashi, S | 1 |
| Chemel, AK | 1 |
| Okoye, M | 1 |
| Scantlen, MD | 1 |
| Tchieu, J | 1 |
| Calder, EL | 1 |
| Le Rouzic, V | 1 |
| Shibata, B | 1 |
| Arab, A | 1 |
| Goodarzi, H | 1 |
| Pasternak, G | 1 |
| Kocsis, JD | 1 |
| Chen, S | 1 |
| Studer, L | 1 |
| Fattahi, F | 1 |
| Rowland, DL | 1 |
| Myers, L | 1 |
| Culver, A | 1 |
| Davidson, JM | 1 |
1 trial available for bupropion and Diabetic Neuropathies
| Article | Year |
|---|---|
Bupropion and sexual function: a placebo-controlled prospective study on diabetic men with erectile dysfunction.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Diabetic Angiopathies; Diabetic Neuropat | 1997 |
1 other study available for bupropion and Diabetic Neuropathies
| Article | Year |
|---|---|
Deriving Schwann cells from hPSCs enables disease modeling and drug discovery for diabetic peripheral neuropathy.
Topics: Animals; Bupropion; Diabetes Mellitus; Diabetic Neuropathies; Drug Discovery; Humans; Mice; Retrospe | 2023 |